KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Cash from Investing Activities (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Cash from Investing Activities data on record, last reported at -$322.0 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 10.58% year-over-year to -$322.0 million; the TTM value through Dec 2025 reached -$2.0 billion, down 122.46%, while the annual FY2025 figure was -$2.0 billion, 122.46% down from the prior year.
  • Cash from Investing Activities reached -$322.0 million in Q4 2025 per ZBH's latest filing, down from -$163.3 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$81.1 million in Q1 2022 and bottomed at -$1.4 billion in Q2 2025.
  • Average Cash from Investing Activities over 5 years is -$230.4 million, with a median of -$159.1 million recorded in 2024.
  • Peak YoY movement for Cash from Investing Activities: skyrocketed 53.45% in 2021, then plummeted 460.49% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$124.0 million in 2021, then grew by 9.27% to -$112.5 million in 2022, then tumbled by 96.27% to -$220.8 million in 2023, then tumbled by 31.88% to -$291.2 million in 2024, then dropped by 10.58% to -$322.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$322.0 million in Q4 2025, -$163.3 million in Q3 2025, and -$1.4 billion in Q2 2025.